GlaxoSmithKline has reached a confidential Zantac cancer lawsuit settlement agreement resolving four cases that were scheduled to go to trial in California beginning next month.
The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.
Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug.
A Zantac cancer lawsuit filed in California will go before a jury in November, however no specific case has yet been selected, according to a Reuters report.
A Zantac bladder cancer lawsuit scheduled to go to trial next month in California has been resolved through a confidential settlement agreement, GlaxoSmithKline says.
Bloomberg News reports that the Department of Defense is in talks with the independent drug testing lab Valisure to have it test generic drugs given to the military for safety…
A California judge will allow Zantac lawsuits to move forward after allowing plaintiffs' expert witnesses to testify.
A House lawmaker is asking FDA whether it plans to investigate GlaxoSmithKline for potentially hiding cancer risks from Zantac for decades in order to maintain profits.
An investigative report indicates GlaxoSmithKline knew Zantac could transform into NDMA, a known cancer-causing chemical, since the drug was first developed, but never told the FDA.
Dozens of Zantac lawsuits filed in New York state courts have been consolidated for pretrial proceedings over claims the recalled heartburn drug may cause cancer.
